Abstract
Ménière’s disease is frequent in our area. It is a disabling pathology that affects the patient’s quality of life. Its etiology and pathophysiology remain unclear and there are some therapeutic alternatives with controversial results. We present our series and treatment protocol for Ménière’s disease and discuss the current evidence regarding its medical treatment. In the last 10 years, 252 patients were diagnosed with Ménière’s disease based on their symptoms, and the results of tonal audiometry, videonystagmography and caloric stimulation tests. All cases received medical treatment according to our management protocol. Ménière’s disease is more frequent in women (54.76%); 83.73% of cases are unilateral. Among these, vertigo was observed in 93.7%, hearing loss in 88.1%, tinnitus in 86.1% and pathologic caloric stimulation tests in 71% (88.27% with a reduced vestibular response). A 5-year follow-up was performed in 89.6% of the patients. Subjective improvement as reported by patients was achieved in 94.4% of the cases. There is great controversy about the medical treatment of Ménière’s disease. We found no evidence for the most adequate medical treatment among the different alternatives described in literature. The patient’s acceptance and understanding of the disease is very important.
Similar content being viewed by others
References
Li JC (2009) Inner ear, Ménière disease, medical treatment. Available via DIALOG. http://emedicine.medscape.com/article/856547-overview. Accessed 28 Jun 2009
(2007) Ménière’s disease. In: CKS (Clinical Knowledge Summaries). Available via DIALOG. http://cks.library.nhs.uk/menieres_disease#288363001. Accessed 23 Sep 2008
(1995) Ménière’s disease. In: Bandolier. Available via DIALOG. http://www.jr2.ox.ac.uk/bandolier
Coelho DH, Lalwani AK (2008) Medical management of Ménière’s disease. Laryngoscope 118:1099–1106
Merchant SN, Adams JC, Nadol JB (2005) Pathophysiology of Ménière’s syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 26:74–81
Philips JS, Prinsley PR (2009) A unified hypothesis for vestibular dysfunction? Otolaryngol Head Neck Surg 140:477–479
Pérez-Garrigues H, López-Escamez JA, Pérez P, Sanz R, Orts M, Marco J et al (2008) Time course of episodes of definitive vertigo in Ménière’s disease. Arch Otolaryngol Head Neck Surg 134:1149–1154
Sajjadi H, Paparella MM (2008) Ménière’s disease. Lancet 372:406–414
Wilkerson RG (2008) Ménière disease. Available via DIALOG. http://emedicine.medscape.com/article/792902-overview
Alles MJRC, Der Gaag MA, Stokroos RJ (2006) Intratympanic steroid therapy for inner ear diseases, a review of the literature. Eur Arch Otorhinolaryngol 263(9):791–797
Yardley L, Kirby S (2006) Evaluation of booklet-based self-management of symptoms in Ménière disease: a randomized controlled trial. Psychosom Med 68(5):762–769
Kirby S, Yardley L (2009) Cognitions associated with anxiety in Ménière’s disease. J Psychosom Res 66:111–118
Salami A, Dellepiane M, Tinelle E, Jankowska B (1984) Double blind study of betahistine and placebo in the treatment of Ménière’s syndrome. Il Valsalva 60:302–312
Fraysse B, Bebear JP, Dubreuil C, Berges C, Dauman R (1991) Betahistine dihydrochloride versus flunarizine. A double blind study on recurrent vertigo with or without cochlear syndrome typical of Menière’s disease. Acta Otolarynngol Suppl 490:1–10
Thirlwall AS, Kundu S (2006) Diuréticos para la enfermedad o el síndrome de Ménière (Revisión Cochrane traducida). Available via DIALOG. http://www.update-software.com
Van Deelen GW, Huizing EH (1986) Use of a diuretic (Dyazide) in the treatment of Menière’s disease. A double-blind crossover placebo-controlled study. ORL J Otolaryngol Relat Spec 48:287–292
Alleman AM, Dornhoffer JL, Arenberg IK, Walker PD (1997) Demonstration of autoantibodies to the endolymphatic sac in Ménière’s disease. Laryngoscope 107:211–215
Harner SG, Kasperbauer JL, Facer GW, Beatty CW (1998) Transtympanic gentamicin for Ménière’s syndrome. Laryngoscope 108:1446–1449
Cohen-Kerem R, Kisilevsky V, Einarson TR, Kozer E, Koren C, Rutka JA (2004) Intratympanic gentamicin for Ménière’s disease: a meta-analysis. Laryngoscope 114(12):2085–2091
Hamid M, Trune D (2008) Issues, indications and controversies regarding intratympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg 16:434–440
Hoffer ME, Balough BJ, Gottshall KR (2006) Delivery of drugs to the inner ear. Curr Opin Otolaryngol Head Neck Surg 14(5):329–331
Wu IC, Minor LB (2003) Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière’s disease. Laryngoscope 113:815–820
Hill SL, Digges EN, Silverstein H (2006) Long-term follow-up after gentamicin application via the Silverstein MicroWick in the treatment of Ménière’s disease. Ear Nose Throat J 85:494–498
Bodmer D, Morong S, Stewart C, Alexander A, Chen JM, Nedzelski JM (2007) Long-term vertigo control in patients after intratympanic gentamicin instillation for Ménière’s disease. Otol Neurotol 28:1140–1144
Peterson WM, Isaacson JE (2007) Current management of Ménière’s disease in an only hearing ear. Otol Neurotol 28:696–699
Harner SG, Driscoll CL, Facer GW, Beatty CW, McDonald TJ (2001) Long-term follow-up of transtympanic gentamicin for Ménière’s syndrome. Otol Neurotol 22:210–214
Van de Heyning PH, Wuyts F, Boudewyns A (2005) Surgical treatment of Ménière’s disease. Curr Opin Neurol 18:23–28
Garduno-Anaya MA, Couthino DT, Hinojosa-Gonzalez R et al (2005) Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière’s disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg 133:285–294
Silverstein H, Isaacson JE, Olds MJ et al (1998) Dexamethasone inner ear perfusion for the treatment of Ménière’s disease: a prospective, randomized, double blind, crossover trial. Am J Otol 19:196–201
Boleas-Aguirre MS, Lin FR, Della Santina CC, Minor LB, Carey JP (2008) Longitudinal results with intratympanic dexamethasone in the treatment of Ménière’s disease. Otol Neurotol 29:33–38
Gates GA, Verrall A, Green JD, Tucci DL, Telian SA (2006) Meniett clinical trial: long-term follow-up. Arch Otolaryngol Head Neck Surg 132(12):1311–1316
Conflict of interest statement
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martín González, C., González, F.M., Trinidad, A. et al. Medical management of Ménière’s disease: a 10-year case series and review of literature. Eur Arch Otorhinolaryngol 267, 1371–1376 (2010). https://doi.org/10.1007/s00405-010-1265-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-010-1265-4